{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:44:55Z","timestamp":1761630295654},"reference-count":51,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,4,1]]},"abstract":"<jats:p>We recently developed a murine protocol for the induction of allogeneic mixed chimerism and tolerance employing nonmyeloablative total body irradiation (TBI), standard-dose bone marrow transplantation (BMT), and costimulation blockade (cobl) with an anti-CD154 monoclonal antibody (mAb) plus CTLA4Ig. We now evaluated whether a short course (1 month) of immunosuppressive drugs, which would be ethically required in the clinical setting of organ transplantation to prevent graft loss in case tolerance is not achieved, interferes with tolerance induced with this regimen. Our results show that calcineurin inhibitors (cyclosporin A [CyA] or tacrolimus [FK]) inhibit development of long-term chimerism and abrogate tolerance induction in this model. Rapamycin (rapa), methylprednisolone (MP), FTY720, and mycophenolate mofetil (MMF), in contrast, have no negative effect on chimerism or tolerance development. Peripheral deletion of donor-reactive T cells, which usually occurs in the weeks following BMT in this model, is blocked by CyA and FK, but not by the other drugs tested. Furthermore, we found that the additional use of compatible immunosuppressive drugs (rapa plus MMF plus MP) allows the dose of TBI to be reduced, so that mixed chimerism and donor skin-graft acceptance can be achieved with 1 Gy using clinically feasible cell numbers. Thus, this protocol of BMT with costimulation blockade can be safely combined with a clinically tested immunosuppressive regimen to permit success with a lower dose of irradiation. These results should facilitate clinical application of this tolerance strategy.<\/jats:p>","DOI":"10.1182\/blood-2002-10-3014","type":"journal-article","created":{"date-parts":[[2003,3,17]],"date-time":"2003-03-17T20:22:55Z","timestamp":1047932575000},"page":"2886-2893","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":144,"title":["The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade"],"prefix":"10.1182","volume":"101","author":[{"given":"Peter","family":"Blaha","sequence":"first","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinda","family":"Bigenzahn","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvonimir","family":"Koporc","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Schmid","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Langer","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Selzer","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helga","family":"Bergmeister","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Wrba","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Kurtz","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Kiss","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich","family":"Roth","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Muehlbacher","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Sykes","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wekerle","sequence":"additional","affiliation":[{"name":"From the Division of Transplantation, Department of Surgery; the Department of Radiotherapy and Radiobiology; the Institute of Biomedical Research; the Institute of Clinical Pathology; and the Surgical Research Laboratories, Vienna General Hospital, University of Vienna, Austria; and the Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111904001431200_B1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.med.52.1.353","article-title":"Mixed chimerism and transplantation tolerance.","volume":"52","author":"Wekerle","year":"2001","journal-title":"Annu Rev Med."},{"key":"2019111904001431200_B2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1084\/jem.169.2.493","article-title":"Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen.","volume":"169","author":"Sharabi","year":"1989","journal-title":"J Exp Med."},{"key":"2019111904001431200_B3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1084\/jem.169.1.213","article-title":"Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.","volume":"169","author":"Mayumi","year":"1989","journal-title":"J Exp Med."},{"key":"2019111904001431200_B4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00007890-199602150-00027","article-title":"Additional mAb injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation.","volume":"61","author":"Tomita","year":"1996","journal-title":"Transplantation."},{"key":"2019111904001431200_B5","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.4049\/jimmunol.157.7.2820","article-title":"Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.","volume":"157","author":"Colson","year":"1996","journal-title":"J Immunol."},{"key":"2019111904001431200_B6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0797-783","article-title":"Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning.","volume":"3","author":"Sykes","year":"1997","journal-title":"Nat Med."},{"key":"2019111904001431200_B7","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood.V89.7.2596","article-title":"Specific tolerance induction and transplantation: a single-day protocol.","volume":"89","author":"De Vries-van der Zwan","year":"1997","journal-title":"Blood."},{"key":"2019111904001431200_B8","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1084\/jem.187.12.2037","article-title":"Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance.","volume":"187","author":"Wekerle","year":"1998","journal-title":"J Exp Med."},{"key":"2019111904001431200_B9","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V99.5.1840","article-title":"A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex\u2013mismatched bone marrow transplantation.","volume":"99","author":"Kean","year":"2002","journal-title":"Blood."},{"key":"2019111904001431200_B10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1182\/blood.V97.2.557","article-title":"Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice.","volume":"97","author":"Quesenberry","year":"2001","journal-title":"Blood."},{"key":"2019111904001431200_B11","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.4049\/jimmunol.166.5.2970","article-title":"CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.","volume":"166","author":"Ito","year":"2001","journal-title":"J Immunol."},{"key":"2019111904001431200_B12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V98.2.467","article-title":"Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.","volume":"98","author":"Taylor","year":"2001","journal-title":"Blood."},{"key":"2019111904001431200_B13","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/00007890-199911150-00022","article-title":"Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.","volume":"68","author":"Wekerle","year":"1999","journal-title":"Transplantation."},{"key":"2019111904001431200_B14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/74731","article-title":"Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.","volume":"6","author":"Wekerle","year":"2000","journal-title":"Nat Med."},{"key":"2019111904001431200_B15","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood.V95.6.2175","article-title":"Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD\/Lt mice.","volume":"95","author":"Seung","year":"2000","journal-title":"Blood."},{"key":"2019111904001431200_B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.165.1.1","article-title":"Administration of anti-CD40 ligand and donor bone marrow leads to hematopoietic chimerism and donor-specific tolerance without cytoreductive conditioning.","volume":"165","author":"Durham","year":"2000","journal-title":"J Immunol."},{"key":"2019111904001431200_B17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.4049\/jimmunol.167.2.1103","article-title":"Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression.","volume":"167","author":"Adams","year":"2001","journal-title":"J Immunol."},{"key":"2019111904001431200_B18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00007890-199811150-00001","article-title":"Recommendations of the expert panel on ethical issues in clinical trials of transplant tolerance.","volume":"66","author":"Rose","year":"1998","journal-title":"Transplantation."},{"key":"2019111904001431200_B19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0952-7915(02)00378-3","article-title":"Mechanisms of transplant tolerance induction using costimulatory blockade.","volume":"14","author":"Wekerle","year":"2002","journal-title":"Curr Opin Immunol."},{"key":"2019111904001431200_B20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","article-title":"Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.","volume":"381","author":"Larsen","year":"1996","journal-title":"Nature."},{"key":"2019111904001431200_B21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/15256","article-title":"Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance.","volume":"5","author":"Li","year":"1999","journal-title":"Nat Med."},{"key":"2019111904001431200_B22","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/15260","article-title":"Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.","volume":"5","author":"Wells","year":"1999","journal-title":"Nat Med."},{"key":"2019111904001431200_B23","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/9536","article-title":"Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.","volume":"5","author":"Kirk","year":"1999","journal-title":"Nat Med."},{"key":"2019111904001431200_B24","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/00007890-200109270-00025","article-title":"Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.","volume":"72","author":"Hausen","year":"2001","journal-title":"Transplantation."},{"key":"2019111904001431200_B25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s002680020071","article-title":"Long-term graft acceptance in rat heart transplantation by CTLA4Ig gene transfection combined with FTY720 treatment.","volume":"25","author":"Ohba","year":"2001","journal-title":"World J Surg."},{"key":"2019111904001431200_B26","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood.V96.3.1166.015k41_1166_1172","article-title":"A novel application of cyclosporine A in nonmyeloablative pretransplant host conditioning for allogeneic BMT.","volume":"96","author":"Nikolic","year":"2000","journal-title":"Blood."},{"key":"2019111904001431200_B27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00007890-199501000-00018","article-title":"Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys.","volume":"59","author":"Kawai","year":"1995","journal-title":"Transplantation."},{"key":"2019111904001431200_B28","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1097\/00007890-200004271-00297","article-title":"The effect of FTY720 (FTY) on donor-specific blood transfusion (DSBT) induced tolerance; discrepancy between heart transplantation (Htx) and intestinal transplantation (Itx) [abstract].","volume":"69","author":"Koshiba","year":"2000","journal-title":"Transplantation."},{"key":"2019111904001431200_B29","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V89.8.3048","article-title":"Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.","volume":"89","author":"Storb","year":"1997","journal-title":"Blood."},{"key":"2019111904001431200_B30","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood.V94.7.2523.419k18_2523_2529","article-title":"Stable mixed chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.","volume":"94","author":"Storb","year":"1999","journal-title":"Blood."},{"key":"2019111904001431200_B31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00007890-200201270-00031","article-title":"What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?","volume":"73","author":"Xun","year":"2002","journal-title":"Transplantation."},{"key":"2019111904001431200_B32","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1097\/00007890-200105150-00025","article-title":"A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function.","volume":"71","author":"Hong","year":"2001","journal-title":"Transplantation."},{"key":"2019111904001431200_B33","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.4049\/jimmunol.166.4.2311","article-title":"Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death.","volume":"166","author":"Wekerle","year":"2001","journal-title":"J Immunol."},{"key":"2019111904001431200_B34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0041-1345(98)01605-4","article-title":"Role of peripheral clonal deletion in tolerance induction with bone marrow transplantation and costimulatory blockade.","volume":"31","author":"Wekerle","year":"1999","journal-title":"Transplant Proc."},{"key":"2019111904001431200_B35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01719234","article-title":"The genetic basis of negative selection of Tcrb-V11+ T cells.","volume":"33","author":"Tomonari","year":"1991","journal-title":"Immunogenetics."},{"key":"2019111904001431200_B36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/349531a0","article-title":"Genes encoding ligands for deletion of Vb11 T cells cosegregate with mammary tumour virus genomes.","volume":"349","author":"Dyson","year":"1991","journal-title":"Nature."},{"key":"2019111904001431200_B37","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.169.4.1405","article-title":"The MHC molecule I-E is necessary but not sufficient for the clonal deletion of VB11 bearing T cells.","volume":"169","author":"Bill","year":"1989","journal-title":"J Exp Med."},{"key":"2019111904001431200_B38","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00007890-200109150-00002","article-title":"FTY720: altered lymphocyte traffic results in allograft protection.","volume":"72","author":"Brinkmann","year":"2001","journal-title":"Transplantation."},{"key":"2019111904001431200_B39","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1084\/jem.170.6.1947","article-title":"Capacity of unprimed CD4+ and CD8+ T cells expressing VB11 receptors to respond to I-E alloantigens in vivo.","volume":"170","author":"Gao","year":"1989","journal-title":"J Exp Med."},{"key":"2019111904001431200_B40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1034\/j.1600-6143.2001.10409.x","article-title":"Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells.","volume":"1","author":"Kurtz","year":"2001","journal-title":"Am J Transplant."},{"key":"2019111904001431200_B41","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","article-title":"Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.","volume":"69","author":"Kreis","year":"2000","journal-title":"Transplantation."},{"key":"2019111904001431200_B42"},{"key":"2019111904001431200_B43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/339625a0","article-title":"Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes.","volume":"339","author":"Shi","year":"1989","journal-title":"Nature."},{"key":"2019111904001431200_B44","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1182\/blood-2002-03-0872","article-title":"The combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.","volume":"100","author":"Taylor","year":"2002","journal-title":"Blood."},{"key":"2019111904001431200_B45","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1172\/JCI8082","article-title":"Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.","volume":"104","author":"Trambley","year":"1999","journal-title":"J Clin Invest."},{"key":"2019111904001431200_B46","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4049\/jimmunol.165.2.1111","article-title":"CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.","volume":"165","author":"Jones","year":"2000","journal-title":"J Immunol."},{"key":"2019111904001431200_B47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4049\/jimmunol.164.1.512","article-title":"Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.","volume":"164","author":"Iwakoshi","year":"2000","journal-title":"J Immunol."},{"key":"2019111904001431200_B48","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/00007890-199811270-00021","article-title":"Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment.","volume":"66","author":"Li","year":"1998","journal-title":"Transplantation."},{"key":"2019111904001431200_B49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00007890-200008150-00005","article-title":"Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction.","volume":"70","author":"Smiley","year":"2000","journal-title":"Transplantation."},{"key":"2019111904001431200_B50","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)11135-2","article-title":"Mixed lymphohaemopoietic chimerism and graft-vs-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone marrow transplantation.","volume":"353","author":"Sykes","year":"1999","journal-title":"Lancet."},{"key":"2019111904001431200_B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3579391","article-title":"Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990.","volume":"146","author":"Pierce","year":"1996","journal-title":"Radiat Res."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/7\/2886\/1273331\/h80703002886.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/7\/2886\/1273331\/h80703002886.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T12:47:17Z","timestamp":1682426837000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/7\/2886\/106710\/The-influence-of-immunosuppressive-drugs-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,1]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-10-3014","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4,1]]}}}